<html>
<head>PUBMED IDs for PARK8</head>
<body bgcolor='#C5F0F2'><h1>PARK8</h1><a href='https://pubmed.ncbi.nlm.nih.gov/14691730/'>The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.</a> December 24  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15541309/'>Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.</a> November 16  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15541308/'>Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.</a> November 16  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15726496/'>Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.</a> February 24  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15732106/'>Familial Parkinson's disease: clinical and genetic analysis of four Basque families.</a> February 26  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15852371/'>Clinical features of LRRK2-associated Parkinson's disease in central Norway.</a> April 27  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15880653/'>An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family.</a> May 10  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15925109/'>LRRK2 R1441G in Spanish patients with Parkinson's disease.</a> June 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16008161/'>A reassessment of the Lewy body.</a> July 13  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16081470/'>PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.</a> August 6  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16131423/'>Genetics of parkinsonism.</a> September 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16254973/'>Common variants of LRRK2 are not associated with sporadic Parkinson's disease.</a> October 29  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16272164/'>Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.</a> November 8  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16643318/'>LRRK2 mutations are a common cause of Parkinson's disease in Spain.</a> April 29  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16671078/'>Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation.</a> May 4  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17017533/'>Clinical and pathologic features of families with LRRK2-associated Parkinson's disease.</a> October 5  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17260967/'>GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease.</a> January 31  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17335904/'>Parkin polymorphisms and environmental exposure: decrease in age at onset of Parkinson's disease.</a> March 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17346966/'>LRK-1, a C. elegans PARK8-related kinase, regulates axonal-dendritic polarity of SV proteins.</a> March 10  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17388990/'>A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.</a> March 29  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17388981/'>Molecular imaging in hereditary forms of parkinsonism.</a> March 29  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17388968/'>Effect of wine phenolics on cytokine-induced C-reactive protein expression.</a> March 29  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17388964/'>Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers.</a> March 29  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17395370/'>Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson's disease families.</a> March 31  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17395331/'>Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis.</a> March 31  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17582365/'>Deciphering the role of heterozygous mutations in genes associated with parkinsonism.</a> June 22  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17582354/'>Heterozygous mutations in genes causing parkinsonism: monogenic disorders go complex.</a> June 22  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17713121/'>[Pathology of familial Parkinson's disease].</a> August 24  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17713120/'>[Clinical molecular genetics for PARK8 (LRRK2)].</a> August 24  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17804834/'>LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.</a> September 7  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18279377/'>Parkinson's disease: a genetic perspective.</a> February 19  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18379513/'>[A PARK8 form of Parkinson's disease: a mutational analysis of the LRRK2 gene in Russian population].</a> April 2  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18445495/'>LRRK2 regulates synaptic vesicle endocytosis.</a> May 1  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18464276/'>Genetic and environmental findings in early-onset Parkinson's disease Brazilian patients.</a> May 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18804399/'>Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes.</a> September 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19142648/'>LRRK2 and neurodegeneration.</a> April 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19319700/'>ParkScreen: a low-cost rapid linkage marker panel for Parkinson's disease.</a> February 13  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19330201/'>Clinical and molecular neuroimaging characteristics of Brazilian patients with Parkinson's disease and mutations in PARK2 or PARK8 genes.</a> February 12  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19804414/'>LRRK2 in Parkinson's disease: in vivo models and approaches for understanding pathogenic roles.</a> February 19  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19824698/'>Identification of the autophosphorylation sites of LRRK2.</a> January 1  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19854095/'>The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.</a> May 5  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20030238/'>[Pathogenesis of sporadic Parkinson's disease: contribution of genetic and environmental risk factors].</a> September 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20030237/'>[Development in researches for familial Parkinson's disease].</a> September 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20177695/'>Effective long-term subthalamic stimulation in PARK8 positive Parkinson's disease.</a> February 18  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20423607/'>Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease.</a> July 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20423577/'>Family history in primary care: understanding GPs' resistance to clinical genetics--qualitative study.</a> December 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20721910/'>Clinical expression of LRRK2 G2019S mutations in the elderly.</a> February 26  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20721882/'>Paracrine signals from mesenchymal cell populations govern the expansion and differentiation of human hepatic stem cells to adult liver fates.</a> October 19  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21238487/'>Î±-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.</a> May 2  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22047502/'>Re-examination of the dimerization state of leucine-rich repeat kinase 2: predominance of the monomeric form.</a> March 16  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22047493/'>Functional analysis of UGT1A4(P24T) and UGT1A4(L48V) variant enzymes.</a> March 17  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22166430/'>Mouse models for LRRK2 Parkinson's disease.</a> August 28  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22166427/'>Genetic reduction of the E3 ubiquitin ligase element, SKP1A and environmental manipulation to emulate cardinal features of Parkinson's disease.</a> August 28  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22525366/'>LRRK2 I2020T mutation is associated with tau pathology.</a> March 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22575234/'>Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson's disease: a meta-analysis.</a> October 24  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22575062/'>Association of Parkinson's disease with six single nucleotide polymorphisms located in four PARK genes in the northern Han Chinese population.</a> October 23  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23227859/'>A case of restless leg syndrome in a family with LRRK2 gene mutation.</a> September 14  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23924436/'>Differential effects of familial parkinson mutations in LRRK2 revealed by a systematic analysis of autophosphorylation.</a> January 15  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23924370/'>Variability of antibiotic susceptibility and toxin production of Staphylococcus aureus strains isolated from skin, soft tissue, and bone related infections.</a> January 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23924366/'>Screening for duplications, deletions and a common intronic mutation detects 35% of second mutations in patients with USH2A monoallelic mutations on Sanger sequencing.</a> January 3  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23924348/'>Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-Î² receptor I internalization and inhibiting transforming growth factor-Î²1 signaling.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24025585/'>Contribution of GTPase activity to LRRK2-associated Parkinson disease.</a> December 15  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24064060/'>Dexamethasone induces the expression of LRRK2 and Î±-synuclein, two genes that when mutated cause Parkinson's disease in an autosomal dominant manner.</a> April 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24488318/'>Structural and functional in silico analysis of LRRK2 missense substitutions.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24729340/'>Low prevalence of most frequent pathogenic variants of six PARK genes in sporadic Parkinson's disease.</a> April 4  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24850078/'>Modeling LRRK2 Pathobiology in Parkinson's Disease: From Yeast to Rodents.</a> September 12  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24849936/'>Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China.</a> January 30  2014<br></body></html>
